1. Home
  2. NBIX vs QXO Comparison

NBIX vs QXO Comparison

Compare NBIX & QXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBIX
  • QXO
  • Stock Information
  • Founded
  • NBIX 1992
  • QXO 1988
  • Country
  • NBIX United States
  • QXO United States
  • Employees
  • NBIX N/A
  • QXO N/A
  • Industry
  • NBIX Biotechnology: Biological Products (No Diagnostic Substances)
  • QXO EDP Services
  • Sector
  • NBIX Health Care
  • QXO Technology
  • Exchange
  • NBIX Nasdaq
  • QXO Nasdaq
  • Market Cap
  • NBIX 14.4B
  • QXO 12.8B
  • IPO Year
  • NBIX 1996
  • QXO N/A
  • Fundamental
  • Price
  • NBIX $140.02
  • QXO $19.06
  • Analyst Decision
  • NBIX Strong Buy
  • QXO Strong Buy
  • Analyst Count
  • NBIX 17
  • QXO 12
  • Target Price
  • NBIX $164.94
  • QXO $33.45
  • AVG Volume (30 Days)
  • NBIX 803.5K
  • QXO 8.6M
  • Earning Date
  • NBIX 10-28-2025
  • QXO 11-12-2025
  • Dividend Yield
  • NBIX N/A
  • QXO N/A
  • EPS Growth
  • NBIX 2.97
  • QXO N/A
  • EPS
  • NBIX 3.39
  • QXO N/A
  • Revenue
  • NBIX $2,509,900,000.00
  • QXO $1,947,673,000.00
  • Revenue This Year
  • NBIX $20.79
  • QXO $12,980.02
  • Revenue Next Year
  • NBIX $14.73
  • QXO $55.71
  • P/E Ratio
  • NBIX $40.99
  • QXO N/A
  • Revenue Growth
  • NBIX 18.42
  • QXO 3309.07
  • 52 Week Low
  • NBIX $84.23
  • QXO $11.85
  • 52 Week High
  • NBIX $154.61
  • QXO $24.69
  • Technical
  • Relative Strength Index (RSI)
  • NBIX 53.84
  • QXO 44.56
  • Support Level
  • NBIX $136.71
  • QXO $18.08
  • Resistance Level
  • NBIX $140.73
  • QXO $19.90
  • Average True Range (ATR)
  • NBIX 3.35
  • QXO 0.89
  • MACD
  • NBIX -0.34
  • QXO -0.01
  • Stochastic Oscillator
  • NBIX 72.66
  • QXO 31.90

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

About QXO QXO Inc. Common Stock

QXO Inc is a building products distribution company engaged in the distribution of roofing, waterproofing and complementary building products in North America. It offers a full suite of business applications, including ERP, warehouse management, accounting, CRM, and business intelligence solutions.

Share on Social Networks: